Medtronic's Affera pulsed field ablation technologies, including Sphere-360 and Sphere-9 catheters, demonstrate impressive safety and efficacy in treating atrial fibrillation, as presented at the Heart Rhythm Society 2025 Annual Meeting.
Medtronic is an Ireland-based medical device company that manufactures and supplies therapeutic and diagnostic equipment to treat chronic diseases across the globe.